cell-2.jpg

You are here: Home > Search Keywords > Search Results
 
 
Aseptic Processing Isolators (Presentation) by Richard L. Friedman, MS June 7, 2001
 
The highlights of this presentation by a leading FDA-CDER authority on aseptic processing isolator systems include basic design and validation approaches as well as feedback by FDA inspectors on various isolator applications during pre-approval inspections.
 
Should Your Company Consider Isolators? by James R. Rickloff, M.S. , Principal Scientist 12-Jan-01
 
It has been generally recognized for years that conventional aseptic processing has its drawbacks when compared to terminal sterilization of a sterile drug product and there is an FDA mandate to improve upon them. Isolation technology is one available means to help accomplish this.
 
Current Trends in Controlled Environments (Presentation) by James R. Rickloff, MS October 29,2000
 
An overview of conventional aseptic processing is presented and it addresses the key issues that corporate decision makers are faced with when implementing isolation technology, such as regulatory requirements and equipment validation focus areas.
 
Microbiological Monitoring in Isolators (Presentation) by James R. Rickloff, M.S. September 18, 2002
 
This presentation reviews the principles of microbial monitoring in isolators, current US and European regulatory requirements for monitoring, and the means to achieve and maintain a germ free environment. The current means to monitor the air and surfaces in isolators is also touched upon.
 

back

 

 

Two locations to better serve clients worldwide.
 

USA Europe
150 Iowa Lane
Cary, NC  27511-4496
(919) 469-8876
(919) 469-4665 Fax
2 Avenue de Vignate
38610 Gieres, France
+33 4 76 63 48 74
+33 4 76 63 48 75 Fax

Brought to you by Advanced Barrier Concepts, Inc.

©2017 Advanced Barrier Concepts, Inc. All rights reserved.
Site Maintained By:
Bayfront Web Design

Administration